Mersana Therapeutics, Inc. (MRSN): Price and Financial Metrics
Mersana Therapeutics, Inc. (MRSN)
Today's Latest Price: $23.87 USD
Updated Nov 23 6:55pm
Add MRSN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
MRSN Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for MRSN is 0 -- better than just 9% of US stocks.
- With a price/sales ratio of 1,859.78, Mersana Therapeutics Inc has a higher such ratio than 99.59% of stocks in our set.
- As for revenue growth, note that MRSN's revenue has grown -98.01% over the past 12 months; that beats the revenue growth of merely 0.76% of US companies in our set.
- Stocks that are quantitatively similar to MRSN, based on their financial statements, market capitalization, and price volatility, are GERN, CBMG, CRNX, SPCE, and ARNA.
- Visit MRSN's SEC page to see the company's official filings. To visit the company's web site, go to www.mersana.com.
MRSN Stock Price Chart Interactive Chart >
MRSN Price/Volume Stats
| Current price | $23.87 | 52-week high | $26.64 |
| Prev. close | $23.35 | 52-week low | $3.20 |
| Day low | $23.38 | Volume | 666,300 |
| Day high | $24.23 | Avg. volume | 1,172,248 |
| 50-day MA | $20.32 | Dividend yield | N/A |
| 200-day MA | $15.86 | Market Cap | 1.64B |
Mersana Therapeutics, Inc. (MRSN) Company Bio
Mersana Therapeutics, Inc. is a biotechnology company that discovers, engineers, and develops antibody drug conjugates to cure various cancers. The company develops immune conjugate therapies to create drugs that enhance patients’ lives. It offers XMT-1522, a drug therapy for tumor models that express relatively low amounts of the HER2 protein; and human anti-HER2 antibody used in XMT-1522. Mersana Therapeutics, Inc. has strategic alliances with Takeda Pharmaceutical Company Limited; Merck Serono; and Asana BioSciences. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was founded in 2001 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...